Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral‐like type I interferon gene response

Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an associati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer Jg. 135; H. 6; S. 1381 - 1389
Hauptverfasser: Cosset, Érika, Petty, Tom J., Dutoit, Valérie, Cordey, Samuel, Padioleau, Ismael, Otten‐Hernandez, Patricia, Farinelli, Laurent, Kaiser, Laurent, Bruyère‐Cerdan, Pascale, Tirefort, Diderik, Amar El‐Dusouqui, Soraya, Nayernia, Zeynab, Krause, Karl‐Heinz, Zdobnov, Evgeny M., Dietrich, Pierre‐Yves, Rigal, Emmanuel, Preynat‐Seauve, Olivier
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Hoboken, NJ Wiley-Blackwell 15.09.2014
Wiley Subscription Services, Inc
Wiley
BlackWell Publishing Ltd
Schlagworte:
ISSN:0020-7136, 1097-0215, 1097-0215
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high‐throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep‐sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral‐like type I interferon response in some specimens. Our findings highlight a discrete and non‐specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high‐resolution virus screening and discovery in human cancers. What's new? Glioblastoma remains frustratingly difficult to cure. There is some evidence to suggest viruses might contribute to glioblastoma, a very tempting possibility, as the involvement of a virus could open doors to formulating novel treatments. However, the role of viruses is still vague and controversial. In this study the authors have developed a robust megagenomic approach to search tumor tissue for the presence of viruses, the first of its kind. They found no common or recurring active viruses, although they did detect a non‐specific interferon pattern resembling an antiviral response.
AbstractList Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high-throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep-sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral-like type I interferon response in some specimens. Our findings highlight a discrete and non-specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high-resolution virus screening and discovery in human cancers.Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high-throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep-sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral-like type I interferon response in some specimens. Our findings highlight a discrete and non-specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high-resolution virus screening and discovery in human cancers.
Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high‐throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep‐sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral‐like type I interferon response in some specimens. Our findings highlight a discrete and non‐specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high‐resolution virus screening and discovery in human cancers. What's new? Glioblastoma remains frustratingly difficult to cure. There is some evidence to suggest viruses might contribute to glioblastoma, a very tempting possibility, as the involvement of a virus could open doors to formulating novel treatments. However, the role of viruses is still vague and controversial. In this study the authors have developed a robust megagenomic approach to search tumor tissue for the presence of viruses, the first of its kind. They found no common or recurring active viruses, although they did detect a non‐specific interferon pattern resembling an antiviral response.
Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high-throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep-sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral-like type I interferon response in some specimens. Our findings highlight a discrete and non-specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high-resolution virus screening and discovery in human cancers. What's new? Glioblastoma remains frustratingly difficult to cure. There is some evidence to suggest viruses might contribute to glioblastoma, a very tempting possibility, as the involvement of a virus could open doors to formulating novel treatments. However, the role of viruses is still vague and controversial. In this study the authors have developed a robust megagenomic approach to search tumor tissue for the presence of viruses, the first of its kind. They found no common or recurring active viruses, although they did detect a non-specific interferon pattern resembling an antiviral response. [PUBLICATION ABSTRACT]
Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high‐throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep‐sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral‐like type I interferon response in some specimens. Our findings highlight a discrete and non‐specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high‐resolution virus screening and discovery in human cancers.
Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high-throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep-sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral-like type I interferon response in some specimens. Our findings highlight a discrete and non-specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high-resolution virus screening and discovery in human cancers. What's new? Glioblastoma remains frustratingly difficult to cure. There is some evidence to suggest viruses might contribute to glioblastoma, a very tempting possibility, as the involvement of a virus could open doors to formulating novel treatments. However, the role of viruses is still vague and controversial. In this study the authors have developed a robust megagenomic approach to search tumor tissue for the presence of viruses, the first of its kind. They found no common or recurring active viruses, although they did detect a non-specific interferon pattern resembling an antiviral response.
Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to be caused by a virus, the discovery of viruses could open the possibility to treat, and perhaps prevent, such a disease. Although an association with viruses such as cytomegalovirus or Simian virus 40 has been strongly suggested, involvement of these and other viruses in the initiation and/or propagation of glioblastoma remains vague, controversial and warrants elucidation. To exhaustively address the association of virus and glioblastoma, we developed and validated a robust metagenomic approach to analyze patient biopsies via high‐throughput sequencing, a sensitive tool for virus screening. In addition to traditional clinical diagnostics, glioblastoma biopsies were deep‐sequenced and analyzed with a multistage computational pipeline to identify known or potentially discover unknown viruses. In contrast to the studies reporting the presence of viral signatures in glioblastoma, no common or recurring active viruses were detected, despite finding an antiviral‐like type I interferon response in some specimens. Our findings highlight a discrete and non‐specific viral signature and uncharacterized short RNA sequences in glioblastoma. This study provides new insights into glioblastoma pathogenesis and defines a general methodology that can be used for high‐resolution virus screening and discovery in human cancers. What's new? Glioblastoma remains frustratingly difficult to cure. There is some evidence to suggest viruses might contribute to glioblastoma, a very tempting possibility, as the involvement of a virus could open doors to formulating novel treatments. However, the role of viruses is still vague and controversial. In this study the authors have developed a robust megagenomic approach to search tumor tissue for the presence of viruses, the first of its kind. They found no common or recurring active viruses, although they did detect a non‐specific interferon pattern resembling an antiviral response.
Author Zdobnov, Evgeny M.
Cosset, Érika
Kaiser, Laurent
Petty, Tom J.
Amar El‐Dusouqui, Soraya
Cordey, Samuel
Farinelli, Laurent
Tirefort, Diderik
Dietrich, Pierre‐Yves
Rigal, Emmanuel
Padioleau, Ismael
Preynat‐Seauve, Olivier
Nayernia, Zeynab
Dutoit, Valérie
Krause, Karl‐Heinz
Otten‐Hernandez, Patricia
Bruyère‐Cerdan, Pascale
Author_xml – sequence: 1
  givenname: Érika
  surname: Cosset
  fullname: Cosset, Érika
  organization: Geneva University Hospitals, University of Geneva
– sequence: 2
  givenname: Tom J.
  surname: Petty
  fullname: Petty, Tom J.
  organization: Swiss Institute of Bioinformatics
– sequence: 3
  givenname: Valérie
  surname: Dutoit
  fullname: Dutoit, Valérie
  organization: Centre of Oncology, Geneva University Hospitals, University of Geneva
– sequence: 4
  givenname: Samuel
  surname: Cordey
  fullname: Cordey, Samuel
  organization: Division of Infectious Diseases and Division of Laboratory Medicine, Geneva University Hospitals
– sequence: 5
  givenname: Ismael
  surname: Padioleau
  fullname: Padioleau, Ismael
  organization: Swiss Institute of Bioinformatics
– sequence: 6
  givenname: Patricia
  surname: Otten‐Hernandez
  fullname: Otten‐Hernandez, Patricia
  organization: Plan‐les‐Ouates
– sequence: 7
  givenname: Laurent
  surname: Farinelli
  fullname: Farinelli, Laurent
  organization: Plan‐les‐Ouates
– sequence: 8
  givenname: Laurent
  surname: Kaiser
  fullname: Kaiser, Laurent
  organization: Division of Infectious Diseases and Division of Laboratory Medicine, Geneva University Hospitals
– sequence: 9
  givenname: Pascale
  surname: Bruyère‐Cerdan
  fullname: Bruyère‐Cerdan, Pascale
  organization: Geneva University Hospitals, University of Geneva
– sequence: 10
  givenname: Diderik
  surname: Tirefort
  fullname: Tirefort, Diderik
  organization: Geneva University Hospitals, University of Geneva
– sequence: 11
  givenname: Soraya
  surname: Amar El‐Dusouqui
  fullname: Amar El‐Dusouqui, Soraya
  organization: Geneva University Hospitals, University of Geneva
– sequence: 12
  givenname: Zeynab
  surname: Nayernia
  fullname: Nayernia, Zeynab
  organization: University Medical Centre, University of Geneva
– sequence: 13
  givenname: Karl‐Heinz
  surname: Krause
  fullname: Krause, Karl‐Heinz
  organization: University Medical Centre, University of Geneva
– sequence: 14
  givenname: Evgeny M.
  surname: Zdobnov
  fullname: Zdobnov, Evgeny M.
  organization: Swiss Institute of Bioinformatics
– sequence: 15
  givenname: Pierre‐Yves
  surname: Dietrich
  fullname: Dietrich, Pierre‐Yves
  organization: Centre of Oncology, Geneva University Hospitals, University of Geneva
– sequence: 16
  givenname: Emmanuel
  surname: Rigal
  fullname: Rigal, Emmanuel
  organization: Geneva University Hospitals, University of Geneva
– sequence: 17
  givenname: Olivier
  surname: Preynat‐Seauve
  fullname: Preynat‐Seauve, Olivier
  organization: Geneva University Hospitals, University of Geneva
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28600117$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24347514$$D View this record in MEDLINE/PubMed
https://hal.sorbonne-universite.fr/hal-04132213$$DView record in HAL
BookMark eNqNksFuEzEQhleoiKaFAy-ALCEkOKQd22vv5oJURUCDInGBs-V1ZhOnu_Zib1LlxpkTz8iT4CVpCxUgTpZmvvnHM_OfZEfOO8yypxTOKAA7t2tzxkpZwINsRGFSjIFRcZSNUg7GBeXyODuJcQ1AqYD8UXbMcp4Xguaj7OvUt13AFbpot0ha7PUSnW-tIdrpZhdtJL4my8b6qtGx960mAbeom0h0FdEZHPJXzl87srVhE8kCY2d7TPW9TRHdfP_yrbFXSPpdh2RGrOsx1Bi8I6kVJrnYeRfxcfawTrL45PCeZp_evvk4vRzPP7ybTS_mYyNkCWMjTcmrfCHqkkGFmheLUvMFSA1cSzCyEiVUGpBONGcUtDSG51JgkeicG36avd7rdpuqxYVB16dPqi7YVoed8tqq3zPOrtTSb1XOuGATmQRe7QVW98ouL-ZqiEFOOWOUb2liXx6aBf95g7FXrY0Gm0Y79JuoqBBU0iKHyX-g6WZMThgk9Pk9dO03Id0rKg6loIwXjP6LSlqcCZYXwzTPfl3H7UA3HknAiwOgo9FNHbQzNt5xpRyMVSTufM-Z4GMMWCtje91bP2zRNoqCGtyqklvVT7feLfK24kb0T-xB_do2uPs7qGbvp_uKHz3z-ko
CODEN IJCNAW
CitedBy_id crossref_primary_10_3390_ijms22052250
crossref_primary_10_1007_s13365_018_0683_8
crossref_primary_10_3389_fonc_2014_00275
crossref_primary_10_3390_v10080408
crossref_primary_10_1038_s44276_024_00051_z
crossref_primary_10_1016_j_omto_2021_03_008
crossref_primary_10_1080_07357907_2020_1793352
crossref_primary_10_3389_fonc_2018_00123
crossref_primary_10_1016_j_biomaterials_2016_08_009
crossref_primary_10_1186_s40478_016_0338_z
crossref_primary_10_1093_neuonc_nou296
crossref_primary_10_1158_1541_7786_MCR_15_0427
crossref_primary_10_3390_medicina59071248
crossref_primary_10_2217_cns_2016_0009
crossref_primary_10_3390_cancers11020186
crossref_primary_10_1002_rmv_2532
crossref_primary_10_3109_02688697_2015_1119241
crossref_primary_10_1002_cam4_3325
crossref_primary_10_1111_trf_14148
crossref_primary_10_1073_pnas_1517584112
crossref_primary_10_1016_j_omto_2019_08_005
crossref_primary_10_29089_2021_21_00202
crossref_primary_10_2217_fvl_2022_0219
crossref_primary_10_1007_s13365_017_0543_y
crossref_primary_10_1093_neuonc_nou167
crossref_primary_10_1016_j_mgene_2015_05_005
crossref_primary_10_3390_cancers13205051
crossref_primary_10_1007_s11910_015_0580_y
crossref_primary_10_1016_j_retram_2019_06_002
Cites_doi 10.1126/science.272.5262.719
10.1215/15228517-2007-035
10.1080/13550280600654573
10.1074/jbc.M302637200
10.1371/journal.pone.0029653
10.1038/modpathol.3800352
10.1186/2047-217X-1-18
10.1038/sj.onc.1206065
10.1038/nri2314
10.1056/NEJMc1302145
10.1073/pnas.0308102100
10.1038/sj.bjc.6602339
10.1016/j.ejca.2007.05.028
10.1007/s00401-005-0991-y
10.3171/jns.2001.95.1.0096
10.1007/s00401-008-0359-1
10.1371/journal.pone.0065953
10.1371/journal.pone.0031386
10.1158/0008-5472.CAN-06-4250
10.1093/neuonc/nor227
10.1128/JVI.00340-13
10.1038/ncpneuro0289
10.1007/s00401-007-0243-4
10.1007/s11060-010-0383-6
10.1016/j.biomaterials.2013.07.006
10.1093/bioinformatics/btp324
10.1002/(SICI)1097-0142(19991115)86:10<2124::AID-CNCR34>3.0.CO;2-D
10.1128/MCB.17.9.5328
10.1056/NEJMoa043330
10.1074/jbc.M307774200
10.1634/stemcells.2008-0600
10.1038/sj.cdd.4400656
10.1101/gr.150151.112
ContentType Journal Article
Copyright 2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC
2015 INIST-CNRS
2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.
2013. This article is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Distributed under a Creative Commons Attribution 4.0 International License
2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC 2013
Copyright_xml – notice: 2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC
– notice: 2015 INIST-CNRS
– notice: 2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.
– notice: 2013. This article is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
– notice: 2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC 2013
DBID 24P
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TO
7U9
H94
K9.
7X8
7T7
8FD
C1K
FR3
P64
RC3
1XC
5PM
DOI 10.1002/ijc.28670
DatabaseName Wiley Online Library Open Access
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
MEDLINE - Academic
Genetics Abstracts
Technology Research Database
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList MEDLINE - Academic
CrossRef
AIDS and Cancer Research Abstracts
AIDS and Cancer Research Abstracts

Genetics Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0215
EndPage 1389
ExternalDocumentID PMC4235296
oai:HAL:hal-04132213v1
3364131001
24347514
28600117
10_1002_ijc_28670
IJC28670
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The 3R Research Foundation (to O.P.‐S.), The ARTERES Foundation (to O.P.‐S. and K.‐H.K.), The ISREC Foundation (to O.P.‐S.), The Egon Naef Foundation (to O.P.‐S.), The Louis Jeantet Foundation (to L.K. and E.M.Z.)
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAMMB
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEFGJ
AEGXH
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIAGR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALVPJ
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SUPJJ
TEORI
UB1
UDS
V2E
V8K
V9Y
W2D
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
CITATION
O8X
.55
.GJ
31~
3O-
53G
8WZ
A6W
AAHHS
AANHP
ABEFU
ABEML
ACBWZ
ACCFJ
ACRPL
ACSCC
ACYXJ
ADNMO
ADZOD
AEEZP
AEQDE
AGHNM
AHEFC
AI.
AIWBW
AJBDE
ALUQN
ASPBG
AVWKF
AZFZN
BDRZF
EX3
FEDTE
GLUZI
HF~
HVGLF
IQODW
M6P
PALCI
SAMSI
VH1
WOW
X7M
Y6R
ZGI
ZXP
AEUQT
AFPWT
CGR
CUY
CVF
ECM
EIF
NPM
RWI
WIN
WRC
WUP
WWO
7T5
7TO
7U9
H94
K9.
7X8
7T7
8FD
C1K
FR3
P64
RC3
1XC
5PM
ID FETCH-LOGICAL-c5680-c6c83b4d5f820bea37d8a3d06a03a60c6b580ba0e19a3210a6cc3465e70be43c3
IEDL.DBID 24P
ISICitedReferencesCount 28
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000339269100011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0020-7136
1097-0215
IngestDate Tue Nov 04 01:54:07 EST 2025
Wed Oct 29 06:29:48 EDT 2025
Tue Oct 07 09:36:38 EDT 2025
Thu Oct 02 07:41:25 EDT 2025
Sat Nov 29 14:52:53 EST 2025
Wed Nov 05 10:27:05 EST 2025
Wed Feb 19 01:52:18 EST 2025
Wed Apr 02 07:24:03 EDT 2025
Sat Nov 29 03:45:31 EST 2025
Tue Nov 18 22:15:46 EST 2025
Tue Nov 11 03:11:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Nervous system diseases
Nucleotide sequence
Cytokine
Malignant tumor
Glioblastoma multiforme
Virus
Malignant glioma
metagenomic analysis
Cancerology
Gene
Central nervous system disease
virus discovery
Antiviral
Genetics
Interferon
antiviral type I interferon response
Sequencing
high-throughput sequencing
Cancer
glioblastoma multiforme
Language English
License Attribution-NonCommercial-NoDerivs
http://creativecommons.org/licenses/by-nc-nd/3.0
CC BY 4.0
2013 The Authors. Published by Wiley Periodicals, Inc. on behalf of UICC.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5680-c6c83b4d5f820bea37d8a3d06a03a60c6b580ba0e19a3210a6cc3465e70be43c3
Notes E.C. and T.J.P. contributed equally to this study.
The authors declare no conflict of interest.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Grant sponsor: The 3R Research Foundation (to O.P.-S.), The ARTERES Foundation (to O.P.-S. and K.-H.K.), The ISREC Foundation (to O.P.-S.), The Egon Naef Foundation (to O.P.-S.), The Louis Jeantet Foundation (to L.K. and E.M.Z.)
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.28670
PMID 24347514
PQID 1543252476
PQPubID 105430
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4235296
hal_primary_oai_HAL_hal_04132213v1
proquest_miscellaneous_1551617409
proquest_miscellaneous_1547526920
proquest_journals_3085123721
proquest_journals_1543252476
pubmed_primary_24347514
pascalfrancis_primary_28600117
crossref_citationtrail_10_1002_ijc_28670
crossref_primary_10_1002_ijc_28670
wiley_primary_10_1002_ijc_28670_IJC28670
PublicationCentury 2000
PublicationDate 15 September 2014
PublicationDateYYYYMMDD 2014-09-15
PublicationDate_xml – month: 09
  year: 2014
  text: 15 September 2014
  day: 15
PublicationDecade 2010
PublicationPlace Hoboken, NJ
PublicationPlace_xml – name: Hoboken, NJ
– name: United States
– name: Hoboken
– name: Oxford, UK
PublicationTitle International journal of cancer
PublicationTitleAlternate Int J Cancer
PublicationYear 2014
Publisher Wiley-Blackwell
Wiley Subscription Services, Inc
Wiley
BlackWell Publishing Ltd
Publisher_xml – name: Wiley-Blackwell
– name: Wiley Subscription Services, Inc
– name: Wiley
– name: BlackWell Publishing Ltd
References 2004; 101
2009; 25
2005; 352
2006; 12
2013; 87
2013; 369
2013; 23(10)
2000; 7
2008; 8
1999; 86
2008; 10
2006; 2
2012; 14
2013; 8
2009; 27
2007; 114
2011; 103
2004; 279
2012; 1
2002; 62
2013; 34
1996; 272
2005; 109
1997; 17
2008; 116
2005; 92
2012; 7
2007; 43
2005; 18
2007; 67
2001; 95
2003; 22
e_1_2_6_32_1
e_1_2_6_10_1
e_1_2_6_31_1
e_1_2_6_30_1
Cobbs CS (e_1_2_6_8_1) 2002; 62
e_1_2_6_19_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_35_1
e_1_2_6_11_1
e_1_2_6_34_1
e_1_2_6_12_1
e_1_2_6_33_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_29_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
22242177 - PLoS One. 2012;7(1):e29653
14623896 - J Biol Chem. 2004 Feb 6;279(6):4066-74
10570441 - Cancer. 1999 Nov 15;86(10):2124-32
19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
22319219 - Neuro Oncol. 2012 Mar;14(3):246-55
16798670 - J Neurovirol. 2006 Apr;12(2):90-9
14755057 - Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1714-9
23899445 - Biomaterials. 2013 Nov;34(33):8279-90
15685439 - Acta Neuropathol. 2005 Jan;109(1):93-108
8614832 - Science. 1996 May 3;272(5262):719-22
11453404 - J Neurosurg. 2001 Jul;95(1):96-101
18351367 - Acta Neuropathol. 2008 Jul;116(1):79-86
15578071 - Mod Pathol. 2005 Jun;18(6):838-43
19074418 - Stem Cells. 2009 Mar;27(3):509-20
18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68
22384016 - PLoS One. 2012;7(2):e31386
16932614 - Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516
15700045 - Br J Cancer. 2005 Feb 28;92(4):747-50
12527914 - Oncogene. 2003 Jan 9;22(1):117-30
23843222 - Genome Res. 2013 Oct;23(10):1721-9
14602726 - J Biol Chem. 2004 Feb 13;279(7):5811-20
10866494 - Cell Death Differ. 2000 Mar;7(3):329-30
23740984 - J Virol. 2013 Aug;87(16):8916-26
23840382 - PLoS One. 2013;8(6):e65953
15758009 - N Engl J Med. 2005 Mar 10;352(10):987-96
9271410 - Mol Cell Biol. 1997 Sep;17(9):5328-37
23587118 - Gigascience. 2012 Dec 27;1(1):18
24004141 - N Engl J Med. 2013 Sep 5;369(10):985-6
17627812 - Eur J Cancer. 2007 Aug;43(12):1833-41
17440099 - Cancer Res. 2007 Apr 15;67(8):3845-52
17618441 - Acta Neuropathol. 2007 Aug;114(2):97-109
17951512 - Neuro Oncol. 2008 Feb;10(1):10-8
20820869 - J Neurooncol. 2011 Jun;103(2):231-8
12067971 - Cancer Res. 2002 Jun 15;62(12):3347-50
References_xml – volume: 279
  start-page: 5811
  year: 2004
  end-page: 5820
  article-title: STAT‐1 interacts with p53 to enhance DNA damage‐induced apoptosis
  publication-title: J Biol Chem
– volume: 109
  start-page: 93
  year: 2005
  end-page: 108
  article-title: Epidemiology and etiology of gliomas
  publication-title: Acta Neuropathol
– volume: 12
  start-page: 90
  year: 2006
  end-page: 99
  article-title: Lack of association of herpesviruses with brain tumors
  publication-title: J Neurovirol
– volume: 352
  start-page: 987
  year: 2005
  end-page: 996
  article-title: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
  publication-title: N Engl J Med
– volume: 10
  start-page: 10
  year: 2008
  end-page: 18
  article-title: Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
  publication-title: Neuro Oncol
– volume: 8
  start-page: 559
  year: 2008
  end-page: 568
  article-title: Interferon‐inducible antiviral effectors
  publication-title: Nat Rev Immunol
– volume: 8
  start-page: e65953
  year: 2013
  article-title: Unbiased approach for virus detection in skin lesions
  publication-title: PLoS One
– volume: 87
  start-page: 8916
  year: 2013
  end-page: 8926
  article-title: Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA‐Seq
  publication-title: J Virol
– volume: 34
  start-page: 8279
  year: 2013
  end-page: 8290
  article-title: The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma
  publication-title: Biomaterials
– volume: 92
  start-page: 747
  year: 2005
  end-page: 750
  article-title: Detection of human cytomegalovirus genome and gene products in central nervous system tumours
  publication-title: Br J Cancer
– volume: 103
  start-page: 231
  year: 2011
  end-page: 238
  article-title: The detection of CMV pp65 and IE1 in glioblastoma multiforme
  publication-title: J Neurooncol
– volume: 67
  start-page: 3845
  year: 2007
  end-page: 3852
  article-title: Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation
  publication-title: Cancer Res
– volume: 279
  start-page: 4066
  year: 2004
  end-page: 4074
  article-title: STAT1‐induced apoptosis is mediated by caspases 2, 3, and 7
  publication-title: J Biol Chem
– volume: 114
  start-page: 97
  year: 2007
  end-page: 109
  article-title: The 2007 WHO classification of tumours of the central nervous system
  publication-title: Acta Neuropathol
– volume: 86
  start-page: 2124
  year: 1999
  end-page: 2132
  article-title: Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag‐p53 and Tag‐pRb complexes in human brain tumors
  publication-title: Cancer
– volume: 14
  start-page: 246
  year: 2012
  end-page: 255
  article-title: Consensus on the role of human cytomegalovirus in glioblastoma
  publication-title: Neuro Oncol
– volume: 25
  start-page: 1754
  year: 2009
  end-page: 1760
  article-title: Fast and accurate short read alignment with Burrows‐Wheeler transform
  publication-title: Bioinformatics
– volume: 23(10)
  start-page: 1721
  year: 2013
  end-page: 1729
  article-title: Pathoscope: species identification and strain attribution with unassembled sequencing data
  publication-title: Genome Res
– volume: 7
  start-page: e29653
  year: 2012
  article-title: Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype‐specific manner
  publication-title: PLoS One
– volume: 1
  start-page: 18
  year: 2012
  article-title: SOAPdenovo2: an empirically improved memory‐efficient short‐read de novo assembler
  publication-title: Gigascience
– volume: 272
  start-page: 719
  year: 1996
  end-page: 722
  article-title: Cell growth arrest and induction of cyclin‐dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1
  publication-title: Science
– volume: 22
  start-page: 117
  year: 2003
  end-page: 130
  article-title: Thiol alkylation inhibits the mitogenic effects of platelet‐derived growth factor and renders it proapoptotic activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1)
  publication-title: Oncogene
– volume: 2
  start-page: 494
  year: 2006
  end-page: 503; quiz 1 p following 16
  article-title: Epidemiology and molecular pathology of glioma
  publication-title: Nat Clin Pract Neurol
– volume: 7
  start-page: e31386
  year: 2012
  article-title: Assessment of metagenomic assembly using simulated next generation sequencing data
  publication-title: PLoS One
– volume: 27
  start-page: 509
  year: 2009
  end-page: 520
  article-title: Development of human nervous tissue upon differentiation of embryonic stem cells in three‐dimensional culture
  publication-title: Stem Cells
– volume: 7
  start-page: 329
  year: 2000
  end-page: 330
  article-title: Opposing actions of STAT‐1 and STAT‐3 on the Bcl‐2 and Bcl‐x promoters
  publication-title: Cell Death Differ
– volume: 62
  start-page: 3347
  year: 2002
  end-page: 3350
  article-title: Human cytomegalovirus infection and expression in human malignant glioma
  publication-title: Cancer Res
– volume: 17
  start-page: 5328
  year: 1997
  end-page: 5337
  article-title: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis
  publication-title: Mol Cell Biol
– volume: 43
  start-page: 1833
  year: 2007
  end-page: 1841
  article-title: Interferon‐gamma mediated up‐regulation of caspase‐8 sensitizes medulloblastoma cells to radio‐ and chemotherapy
  publication-title: Eur J Cancer
– volume: 369
  start-page: 985
  year: 2013
  end-page: 986
  article-title: Survival in patients with glioblastoma receiving valganciclovir
  publication-title: N Engl J Med
– volume: 95
  start-page: 96
  year: 2001
  end-page: 101
  article-title: Detection of simian virus 40 DNA sequence in human primary glioblastomas multiforme
  publication-title: J Neurosurg
– volume: 116
  start-page: 79
  year: 2008
  end-page: 86
  article-title: Detection of human cytomegalovirus in different histological types of gliomas
  publication-title: Acta Neuropathol
– volume: 18
  start-page: 838
  year: 2005
  end-page: 843
  article-title: Lack of association of cytomegalovirus with human brain tumors
  publication-title: Mod Pathol
– volume: 101
  start-page: 1714
  year: 2004
  end-page: 1719
  article-title: STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells
  publication-title: Proc Natl Acad Sci U S A
– ident: e_1_2_6_30_1
  doi: 10.1126/science.272.5262.719
– ident: e_1_2_6_9_1
  doi: 10.1215/15228517-2007-035
– ident: e_1_2_6_16_1
  doi: 10.1080/13550280600654573
– ident: e_1_2_6_31_1
  doi: 10.1074/jbc.M302637200
– ident: e_1_2_6_23_1
  doi: 10.1371/journal.pone.0029653
– volume: 62
  start-page: 3347
  year: 2002
  ident: e_1_2_6_8_1
  article-title: Human cytomegalovirus infection and expression in human malignant glioma
  publication-title: Cancer Res
– ident: e_1_2_6_15_1
  doi: 10.1038/modpathol.3800352
– ident: e_1_2_6_21_1
  doi: 10.1186/2047-217X-1-18
– ident: e_1_2_6_26_1
  doi: 10.1038/sj.onc.1206065
– ident: e_1_2_6_22_1
  doi: 10.1038/nri2314
– ident: e_1_2_6_14_1
  doi: 10.1056/NEJMc1302145
– ident: e_1_2_6_24_1
  doi: 10.1073/pnas.0308102100
– ident: e_1_2_6_10_1
  doi: 10.1038/sj.bjc.6602339
– ident: e_1_2_6_28_1
  doi: 10.1016/j.ejca.2007.05.028
– ident: e_1_2_6_5_1
  doi: 10.1007/s00401-005-0991-y
– ident: e_1_2_6_6_1
  doi: 10.3171/jns.2001.95.1.0096
– ident: e_1_2_6_11_1
  doi: 10.1007/s00401-008-0359-1
– ident: e_1_2_6_17_1
  doi: 10.1371/journal.pone.0065953
– ident: e_1_2_6_35_1
  doi: 10.1371/journal.pone.0031386
– ident: e_1_2_6_25_1
  doi: 10.1158/0008-5472.CAN-06-4250
– ident: e_1_2_6_13_1
  doi: 10.1093/neuonc/nor227
– ident: e_1_2_6_18_1
  doi: 10.1128/JVI.00340-13
– ident: e_1_2_6_4_1
  doi: 10.1038/ncpneuro0289
– ident: e_1_2_6_2_1
  doi: 10.1007/s00401-007-0243-4
– ident: e_1_2_6_12_1
  doi: 10.1007/s11060-010-0383-6
– ident: e_1_2_6_33_1
  doi: 10.1016/j.biomaterials.2013.07.006
– ident: e_1_2_6_20_1
  doi: 10.1093/bioinformatics/btp324
– ident: e_1_2_6_7_1
  doi: 10.1002/(SICI)1097-0142(19991115)86:10<2124::AID-CNCR34>3.0.CO;2-D
– ident: e_1_2_6_27_1
  doi: 10.1128/MCB.17.9.5328
– ident: e_1_2_6_3_1
  doi: 10.1056/NEJMoa043330
– ident: e_1_2_6_29_1
  doi: 10.1074/jbc.M307774200
– ident: e_1_2_6_19_1
  doi: 10.1634/stemcells.2008-0600
– ident: e_1_2_6_32_1
  doi: 10.1038/sj.cdd.4400656
– ident: e_1_2_6_34_1
  doi: 10.1101/gr.150151.112
– reference: 22384016 - PLoS One. 2012;7(2):e31386
– reference: 23899445 - Biomaterials. 2013 Nov;34(33):8279-90
– reference: 19074418 - Stem Cells. 2009 Mar;27(3):509-20
– reference: 17618441 - Acta Neuropathol. 2007 Aug;114(2):97-109
– reference: 23843222 - Genome Res. 2013 Oct;23(10):1721-9
– reference: 14755057 - Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1714-9
– reference: 18575461 - Nat Rev Immunol. 2008 Jul;8(7):559-68
– reference: 14623896 - J Biol Chem. 2004 Feb 6;279(6):4066-74
– reference: 12527914 - Oncogene. 2003 Jan 9;22(1):117-30
– reference: 23587118 - Gigascience. 2012 Dec 27;1(1):18
– reference: 16932614 - Nat Clin Pract Neurol. 2006 Sep;2(9):494-503; quiz 1 p following 516
– reference: 24004141 - N Engl J Med. 2013 Sep 5;369(10):985-6
– reference: 11453404 - J Neurosurg. 2001 Jul;95(1):96-101
– reference: 8614832 - Science. 1996 May 3;272(5262):719-22
– reference: 9271410 - Mol Cell Biol. 1997 Sep;17(9):5328-37
– reference: 15700045 - Br J Cancer. 2005 Feb 28;92(4):747-50
– reference: 12067971 - Cancer Res. 2002 Jun 15;62(12):3347-50
– reference: 10570441 - Cancer. 1999 Nov 15;86(10):2124-32
– reference: 22242177 - PLoS One. 2012;7(1):e29653
– reference: 22319219 - Neuro Oncol. 2012 Mar;14(3):246-55
– reference: 17627812 - Eur J Cancer. 2007 Aug;43(12):1833-41
– reference: 18351367 - Acta Neuropathol. 2008 Jul;116(1):79-86
– reference: 23740984 - J Virol. 2013 Aug;87(16):8916-26
– reference: 10866494 - Cell Death Differ. 2000 Mar;7(3):329-30
– reference: 17951512 - Neuro Oncol. 2008 Feb;10(1):10-8
– reference: 15685439 - Acta Neuropathol. 2005 Jan;109(1):93-108
– reference: 15578071 - Mod Pathol. 2005 Jun;18(6):838-43
– reference: 19451168 - Bioinformatics. 2009 Jul 15;25(14):1754-60
– reference: 14602726 - J Biol Chem. 2004 Feb 13;279(7):5811-20
– reference: 15758009 - N Engl J Med. 2005 Mar 10;352(10):987-96
– reference: 16798670 - J Neurovirol. 2006 Apr;12(2):90-9
– reference: 20820869 - J Neurooncol. 2011 Jun;103(2):231-8
– reference: 23840382 - PLoS One. 2013;8(6):e65953
– reference: 17440099 - Cancer Res. 2007 Apr 15;67(8):3845-52
SSID ssj0011504
Score 2.2942936
Snippet Glioblastoma is a deadly malignant brain tumor and one of the most incurable forms of cancer in need of new therapeutic targets. As some cancers are known to...
SourceID pubmedcentral
hal
proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1381
SubjectTerms Antibodies, Viral - blood
Antiviral drugs
antiviral type I interferon response
Biological and medical sciences
Biopsy
Brain cancer
Brain Neoplasms - genetics
Brain Neoplasms - immunology
Brain Neoplasms - virology
Brain tumors
Cancer
Computational neuroscience
Cytomegalovirus
Cytomegalovirus - immunology
Genomics
Glioblastoma
Glioblastoma - genetics
Glioblastoma - virology
glioblastoma multiforme
Glioma
High-Throughput Nucleotide Sequencing
high‐throughput sequencing
Humans
Immunoglobulin G - blood
Immunoglobulin M - blood
Infectious Causes of Cancer
Interferon
Interferon Type I - immunology
Life Sciences
Medical diagnosis
Medical research
Medical sciences
Medical screening
metagenomic analysis
Metagenomics
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
Neurology
Pathogenesis
RNA viruses
Simian virus 40
Targeted cancer therapy
Therapeutic targets
Tumors
Tumors of the nervous system. Phacomatoses
virus discovery
Viruses
Title Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral‐like type I interferon gene response
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fijc.28670
https://www.ncbi.nlm.nih.gov/pubmed/24347514
https://www.proquest.com/docview/1543252476
https://www.proquest.com/docview/3085123721
https://www.proquest.com/docview/1547526920
https://www.proquest.com/docview/1551617409
https://hal.sorbonne-universite.fr/hal-04132213
https://pubmed.ncbi.nlm.nih.gov/PMC4235296
Volume 135
WOSCitedRecordID wos000339269100011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1097-0215
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0011504
  issn: 0020-7136
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKi1AlxLsQKCuDOHAJdWLHccSpKqxaVKoKUWlvkeM4bGA3qbKPM2dO_EZ-CTNONmXFgpC4rFY7E2c9Gdvf2JNvCHkRiVjnOsl9mWnpCyWsnxQJ8w2D1VAnhTQsd8Um4rMzNRol51vk9epdmJYfot9ww5Hh5msc4DqbHVyRhpafzatQyRji9Z0g4ArrNoTivD9CAKTTUTAzHyIxuaIVYuFBf-naYnRtjKmQNy_1DKxTtGUtNuHO39Mnf4W1bl0a3v6vHt0htzo4Sg9b_7lLtmx1j9x43x243yffcL5o7LhNc6dTO9fI6jotDdUdnQmtC_ppUtYZ4PB5PdUUSaHAqSncFqcNlOPOXUWXZbOY0RwP9-cWrsfCFdCzH1-_T8ovluJuMD2hSGDRFLapKwq3stCcy-K1D8jF8O3Ho2O_K9_gm0gqeNzSKJ6JPCoAZWRW8zhXmudMasa1ZEZmkWKZZjZINL5JpKUxXMjIxqAtuOF7ZLuqK_uI0DhLZFZYAHNSikInKit0oTRLQmMQNHnk5eo5pqbjNscSG5O0ZWUOU7Bt6mzrkee96mVL6LFRCZyhlyMF9_HhaYq_MYHxe8CXgUcGa77Sq0MTjmrPI_sr50m7mWGWAmTlYRSKWG4Uc4TAIYe43CPPejEMeTzH0ZWtF66JGAvDh-xvOhFGrhC9e-Rh665X_09waCAQHonXHHmtv-uSqhw76nEA33hQD_Z2jvxnC6Yn747cl8f_rvqE7AIcFZiNE0T7ZHveLOxTct0s5-WsGbjRDZ_xSA3IzpsPw4vTn0TqWFs
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKQRQJ8X4ESjGIQy-h3thxEolLVVHtwnbVQ5F6ixzHYVN2kyqb3TNnTvxGfgkzTjYlYkFI3KL1xFlPxvY3nsk3hLzxRaBSFaWuTJR0RSiMG2URczWD3VBFmdQstcUmgskkPD-PTrfIu_W3MA0_RHfghjPDrtc4wfFA-uCKNTS_0G-9UAbgsF8XsMuglXvitIshANRpOZiZC66YXPMKMe-gu7W3G12bYi7k7Uu1APVkTV2LTcDz9_zJX3Gt3ZiO7_7fkO6ROy0gpYeNBd0nW6Z4QG6etCH3h-QbrhiVmTaJ7nRuaoW8rvNcU9USmtAyo59neZkAEq_LuaJICwVmTVWywIUD2_HsrqCrvFouaIrh_drA_Vi6Aob24-v3Wf7FUDwPpiOKFBZVZqqyoPAoA93ZPF7ziHw6fn92NHTbAg6u9mUIL1zqkCci9TPAGYlRPEhDxVMmFeNKMi0TP2SJYmYQKfyWSEmtuZC-CUBacM0fk-2iLMxTQoMkkklmAM5JKTIVhUmmslCxyNMaYZND9tcvMtYtuzkW2ZjFDS-zF4NuY6tbh7zuRC8bSo-NQmANXTuScA8PxzH-xgR68AO-Gjhkr2csnTh0Ycn2HLK7tp64XRsWMYBW7vmeCOTGZo4g2OPgmTvkVdcMkx4jOaow5dJ2EWBpeI_9TcZH3xX8d4c8aez16v8JDh0MhEOCniX3xttvKfKpJR8H-I2hetC3teQ_azAefTiyF8_-XfQl2RmenYzj8Wjy8Tm5BeBUYG7OwN8l23W1NC_IDb2q80W1Z6f6T76rWb4
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELaWLlohId6PwLIYxIFLWDd2nETistql2kKpVoiV9hY5jk0DbVIlbc-cOfEb-SXMJGmWioKQuEWdiVNPxvY39uQbQl74IlCpilJXJkq6IhTGjWzEXM1gNVSRlZqldbGJYDwOLy6isx3yev0tTMMP0W244cio52sc4Gae2sNL1tDss37lhTKAgH1XYBGZHtk9-TA4H3WnCAB2WhZm5kIwJtfMQsw77G7eWI-uTDAb8vpcVWAg21S22AY9f8-g_BXZ1kvT4Ob_deoWudFCUnrU-NBtsmPyO2TvfXvofpd8wzmjNJMm1Z3OzEIhs-ss01S1lCa0sPTTNCsSwOKLYqYoEkOBY1OVVDh1oBx373K6ysplRVM84F8YuB-LV0DXfnz9Ps2-GIo7wnRIkcSitKYscgqPMtBcnclr7pHzwZuPx6duW8LB1b4M4ZVLHfJEpL4FpJEYxYM0VDxlUjGuJNMy8UOWKGb6kcKviZTUmgvpmwC0Bdf8PunlRW4eEhokkUysAUAnpbAqChOrbKhY5GmNwMkhL9cvMtYtvzmW2ZjGDTOzF4Nt49q2Dnneqc4bUo-tSuANnRxpuE-PRjH-xgTG8H2-6jvkYMNZOnVooqbbc8j-2nvidnaoYoCt3PM9EcitYo4w2OMQmzvkWSeGYY9nOSo3xbJuIsDi8B77m46P0StE8A550Pjr5f8THBroC4cEG5680d9NSZ5NavpxAOB4WA_2rj35zxaMh2-P64tH_676lOydnQzi0XD87jG5BuhUYHJO398nvUW5NE_IVb1aZFV50I71n_0pWtQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comprehensive+metagenomic+analysis+of+glioblastoma+reveals+absence+of+known+virus+despite+antiviral%E2%80%90like+type+I+interferon+gene+response&rft.jtitle=International+journal+of+cancer&rft.au=Cosset%2C+%C3%89rika&rft.au=Petty%2C+Tom+J.&rft.au=Dutoit%2C+Val%C3%A9rie&rft.au=Cordey%2C+Samuel&rft.date=2014-09-15&rft.issn=0020-7136&rft.eissn=1097-0215&rft.volume=135&rft.issue=6&rft.spage=1381&rft.epage=1389&rft_id=info:doi/10.1002%2Fijc.28670&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ijc_28670
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0020-7136&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0020-7136&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0020-7136&client=summon